Cell and Gene Therapy Catapult
Stevenage, United Kingdom
National Center
Compare CAR-T CDMOs in Europe
Compare CAR-T CDMOs in UK
Compare Cell Therapy CDMOs in Europe
Compare Cell Therapy CDMOs in UK
Compare AAV CDMOs in Europe
Compare AAV CDMOs in UK
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
59.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
○ EMA GMP
○ MHRA GMP
Quick Facts: Cell and Gene Therapy Catapult
- Signal Score
- 59.0/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Stevenage, United Kingdom
- Modalities
- CAR-T, Cell Therapy, AAV
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Cell and Gene Therapy Catapult
CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Stevenage, UK
Modalities: CAR-T, Cell Therapy, AAV
Capacity assessment: 58.0/100
Sites: Stevenage, UK
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals1 articles (not scored)
1 manufacturing site: Stevenage, UK
Modalities: CAR-T, Cell Therapy, AAV
Capacity assessment: 58.0/100
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
Cell and Gene Therapy Catapult Establishes Technology Advisory Board - The Medicine Maker
Cell and Gene Therapy Catapult Establishes Technology Advisory Board The Medicine Maker
Frequently Asked Questions About Cell and Gene Therapy Catapult
What is Cell and Gene Therapy Catapult's CDMO Signal Score?
Cell and Gene Therapy Catapult has a Signal Score of 59/100, based on quality, operations, financial stability, and capacity data.
Evaluating Cell and Gene Therapy Catapult for a manufacturing program?
Use the free AI matchmaker to compare Cell and Gene Therapy Catapult against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Rose BioSolutions
Rockville, MD · Memphis, TN · Keele, United Kingdom
Signal Score: 64.0
AAV, Lentiviral, Adenoviral, Plasmid, Cell Therapy, CAR-T
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 82.7
CAR-T, Cell Therapy, AAV, ADC, Monoclonal Antibody
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
OmniaBio
Hamilton, ON
Signal Score: 61.5
AAV, Lentiviral, CAR-T, Cell Therapy
Compare Cell and Gene Therapy Catapult with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.